|
|
.
See Category: Neoplasms
See Header: Squamous cell carcinoma skin/ ear and external auric canal
ICD-10 (CM) Code and Descriptor
|
C44.222 |
Squamous cell carcinoma of skin of right ear and external auricular canal
|
C44222 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 54.81%
|
27.57%
|
7.24%
|
3.17%
|
1.92%
|
1.25%
|
0.75%
|
0.87%
|
1.11%
|
0.41%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.222*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,997
|
3,192
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,854
|
1,861
|
|
77386
|
NTSTY MODUL RAD TX DLVR CPLX |
1,085
|
1,087
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
941
|
973
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
915
|
916
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
612
|
1,032
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
509
|
514
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
451
|
12,227
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
422
|
422
|
|
80053
|
COMPREHEN METABOLIC PANEL |
408
|
408
|
|
17312
|
MOHS ADDL STAGE |
399
|
473
|
|
J3010
|
FENTANYL CITRATE INJECTION |
398
|
540
|
|
77336
|
RADIATION PHYSICS CONSULT |
396
|
396
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
323
|
1,202
|
|
J2405
|
ONDANSETRON HCL INJECTION |
318
|
1,320
|
|
15260
|
FTH/GFT FR N/E/E/L 20 SQCM/< |
302
|
302
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
265
|
266
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
258
|
24,031
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
254
|
992
|
|
14060
|
TIS TRNFR E/N/E/L 10 SQ CM/< |
238
|
238
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.222 related to the following DRG Codes:
606-607
|
